Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
| Autor: | C Roca-Guerrero, M Rizzo, I Colomer-Asenjo, F Taibi-Hajjami, Antoni Martínez-Rubio, M Bonastre-Thio, M Sutil-Vega, G Cabello-Molina, S Marín-López, D García-Vega, M Panelo-Rubio |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty Ejection fraction business.industry Cardiomyopathy Atrial fibrillation medicine.disease ISCP Posters Discontinuation Tolerability lcsh:RC666-701 RC666-701 Internal medicine Heart failure medicine Cardiology Diseases of the circulatory (Cardiovascular) system Myocardial infarction Cardiology and Cardiovascular Medicine business Sacubitril Valsartan |
| Zdroj: | European Cardiology Review, Vol 15, Iss, Pp e32-(2020) European Cardiology Review |
| ISSN: | 1758-3764 1758-3756 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|